Recent share price weakness has improved the value on offer in the stock and so UBS upgrades to a Neutral rating.
Earnings forecasts and price target are unchanged.
Sector: Health Care Equipment & Services.
Target price is $11.21.Current Price is $10.71. Difference: $0.50 – (brackets indicate current price is over target). If SHL meets the UBS target it will return approximately 4% (excluding dividends, fees and charges – negative figures indicate an expected loss).